InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

iRhythm Holdings, Inc.

IRTC Clue Score51
United States Fiscal year ends December CIK 0001388658 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

45
Insider
Date
Role
Action
Shares
Price
Amount
Daniel G. Wilson
2 Sep 2026
Chief Financial Officer
Sell
773
$121.83
$94.17K
Minang Turakhia
10 Aug 2026
Chief Med/Sci Ofcr EVP Advtech
Sell
7,093
$124.65
$884.15K
Sumi Shrishrimal
10 Aug 2026
EVP, Chief Risk Officer
Sell
5,372
$124.65
$669.64K
Chad Patterson
10 Aug 2026
Chief Comm & Product Officer
Sell
7,093
$124.65
$884.17K
Patrick Michael Murphy
10 Aug 2026
CBO and CLO
Sell
7,093
$124.65
$884.16K
Quentin S. Blackford
10 Aug 2026
President and CEO
Sell
26,859
$124.65
$3.35M
Chad Patterson
3 Aug 2026
Chief Comm & Product Officer
Sell
2,712
$122.12
$331.19K
Julianne Rodda
3 Aug 2026
EVP, Chief People Officer
Sell
2,112
$122.12
$257.92K
Mervin Smith
3 Aug 2026
EVP Strategic Business Ops
Sell
617
$122.12
$75.35K
Sean Clinton Freeman
2 Jul 2026
EVP, Strategy & Corp Devt
Sell
918
$124.71
$114.48K
Minang Turakhia
2 Jul 2026
Chief Med/Sci Ofcr EVP Advtech
Sell
1,423
$124.71
$177.46K
Marc Wade Rosenbaum
2 Jun 2026
Chief Accounting Officer
Sell
729
$108.19
$78.87K
Sumi Shrishrimal
2 Jun 2026
EVP, Chief Risk Officer
Sell
1,716
$108.19
$185.65K
Brian Lee Lawrence
4 May 2026
Chief Technology Officer
Sell
1,014
$120.80
$122.49K
Quentin S. Blackford
2 Mar 2026
President and CEO
Sell
5,423
$128.44
$696.55K
Quentin S. Blackford
2 Mar 2026
President and CEO
Sell
4,043
$128.44
$519.29K
Quentin S. Blackford
2 Mar 2026
President and CEO
Sell
4,347
$128.44
$558.33K
Daniel G. Wilson
2 Mar 2026
Chief Financial Officer
Sell
1,261
$128.45
$161.98K
Daniel G. Wilson
2 Mar 2026
Chief Financial Officer
Sell
564
$128.45
$72.45K
Daniel G. Wilson
2 Mar 2026
Chief Financial Officer
Sell
815
$128.44
$104.68K
Daniel G. Wilson
2 Mar 2026
Chief Financial Officer
Sell
755
$128.44
$96.97K
Marc Wade Rosenbaum
2 Mar 2026
Chief Accounting Officer
Sell
417
$128.45
$53.56K
Marc Wade Rosenbaum
2 Mar 2026
Chief Accounting Officer
Sell
399
$128.45
$51.25K
Patrick Michael Murphy
2 Mar 2026
CBO and CLO
Sell
1,139
$128.45
$146.30K
Patrick Michael Murphy
2 Mar 2026
CBO and CLO
Sell
1,190
$128.44
$152.85K
Patrick Michael Murphy
2 Mar 2026
CBO and CLO
Sell
2,028
$128.44
$260.47K
Chad Patterson
2 Mar 2026
Chief Comm & Product Officer
Sell
3,030
$128.44
$389.19K
Chad Patterson
2 Mar 2026
Chief Comm & Product Officer
Sell
1,414
$128.44
$181.62K
Mervin Smith
2 Mar 2026
EVP Strategic Business Ops
Sell
600
$128.44
$77.07K
Mervin Smith
2 Mar 2026
EVP Strategic Business Ops
Sell
752
$128.44
$96.59K
Sumi Shrishrimal
2 Mar 2026
EVP, Chief Risk Officer
Sell
978
$128.44
$125.62K
Sumi Shrishrimal
2 Mar 2026
EVP, Chief Risk Officer
Sell
906
$128.44
$116.37K
Sumi Shrishrimal
2 Mar 2026
EVP, Chief Risk Officer
Sell
946
$128.44
$121.50K
Minang Turakhia
2 Mar 2026
Chief Med/Sci Ofcr EVP Advtech
Sell
1,230
$128.45
$158.00K
Minang Turakhia
2 Mar 2026
Chief Med/Sci Ofcr EVP Advtech
Sell
1,310
$128.45
$168.26K
Minang Turakhia
2 Mar 2026
Chief Med/Sci Ofcr EVP Advtech
Sell
1,487
$128.45
$191.00K
Quentin S. Blackford
25 Feb 2026
President and CEO
Sell
25,540
$135.42
$3.46M
Patrick Michael Murphy
25 Feb 2026
CBO and CLO
Sell
7,805
$135.42
$1.06M
Chad Patterson
25 Feb 2026
Chief Comm & Product Officer
Sell
8,967
$135.42
$1.21M
Marc Wade Rosenbaum
25 Feb 2026
Chief Accounting Officer
Sell
4,797
$135.42
$649.60K
Sumi Shrishrimal
25 Feb 2026
EVP, Chief Risk Officer
Sell
6,217
$135.42
$841.90K
Mervin Smith
25 Feb 2026
EVP Strategic Business Ops
Sell
4,041
$135.42
$547.23K
Minang Turakhia
25 Feb 2026
Chief Med/Sci Ofcr EVP Advtech
Sell
7,804
$135.42
$1.06M
Daniel G. Wilson
25 Feb 2026
Chief Financial Officer
Sell
5,188
$135.42
$702.55K
Patrick Michael Murphy
2 Dec 2025
CBO and CLO
Sell
2,478
$184.83
$458.01K
Show all 65 transactions →

What was left out

Form 4 filings counted 63
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 15
Sales at will 45
Transactions with no price 0
Shares from compensation/vesting 354,572
History held since 21 Oct 2016